Drugs and Pharmaceuticals
home site map

European four huge opportunities in emerging generics market - Generic Drugs - pharmaceutical industries

Expected in the next 5 years, the global Generic Market will grow at a rate of 9%. Appeared in Europe four emerging generics market?? France, Italy, Portugal and Spain. The next five years, four countries, generic drug market will double-digit growth rate.

France French pharmaceutical market across Western Europe, ranked third, in 2008 the medical expenditure of 34.07 billion euros (about 50.1 billion U.S. dollars), the year 2013 will reach 38.81 billion euros (about 49.12 billion U.S. dollars) to the euro calculated the average annual compound growth rate (CAGR) to 2.64%. According to market research firm Espicom statistics, in 2007 the French generic market with retail prices accounted for 3.7 billion dollars, accounted for 8.6% of the overall pharmaceutical market. French generic market is expected to the actual growth rate of 15%, or 2012 to reach 7.4 billion U.S. dollars, accounting for 15.5% of the overall pharmaceutical market. But the current situation, the French generic drugs still in the low stage of development.

French Government is trying ways to control escalating medical costs, reduced through the use of generic drugs Drugs Expenditure as a major objective of the French Government. Currently, France has many medium-sized generic drug companies, but these companies are mostly foreign companies, such as MerckKGaA (2007 acquired by U.S. Mylan), Sandoz, Ranbaxy and Teva. In 2006, MerckKGaA established through the expansion of the generics market in France's leading position, accounting for the French pharmacies Sell 25.5% of market share and sales of 34% share of the hospital. France's leader in generic drugs is Servier's Biogaran.

Portugal In Portugal, a number of generic drug prices are high compared with the original research and drugs do not have the price advantage, so the market penetration of generic drugs is limited. But now the Government of Portugal has taken many measures to reduce the price of generic drugs, including the establishment of the basis of 2007 market share of the cumulative price reduction plan. Monitoring bodies, according to BMI British international business statistics, the program in 2008 on 1,860 kinds of sales impact of generic drugs, including ramipril, Lisinopril , Paxil, etc..

According to Portugal Pharmaceutical companies Association published data, due to financial crisis the public revenue, the Portuguese pharmaceutical market growth for 10 years after the decline occurred in 2009, for the first time, the annual drug sales will decline to 33 million euros (4.9 billion U.S. dollars) , and last year fell 8.5%. According to BMI forecasts that by 2013, the Portuguese pharmaceutical market value will reach 4.1 billion euros (about 5.42 billion U.S. dollars), in dollar terms of compound annual growth rate of 0.41%. In 2008, Portugal generic sales was 10.4 billion U.S. dollars, accounted for 19.6% of the total pharmaceutical market is expected by 2013 will account for 31.6% of the total pharmaceutical market.

2008 in Portugal's major pharmaceutical markets generic drugs are: decrease in plasma Cholesterol Concentrations of simvastatin (1.28 million); treatment of indigestion, stomach ulcers and gastroesophageal reflux omeprazole (1.16 million) and lansoprazole (0.35 million); treatment of hypertension losartan (027 million U.S. dollars), and blood lipid of pravastatin (0.26 billion U.S. dollars).

At present, the Portuguese generics market, the main characteristics of many and scattered, and all enterprises have very low market share. In a leadership position in the domestic generic drug manufacturers have Farmoz (under Tecnimede), Generis (under Farma-APS), Medinfar, Hovione, Bluepharma and ToLife. Foreign generic producers include Actavis, Alter, Merck generics business unit (acquired in 2007 by Mylan), ratiopharm, Stada and Winthrop. In addition, two major manufacturers of generic drugs in Brazil Medley and EMS also has small branches in Portugal.

We are high quality suppliers, our products such as Tile texture , china Mosaic texture for oversee buyer. To know more, please visits decorative wall panel.


Rate This Article:

Drugs and Pharmaceuticals

Advancements in Mobile Technology Resolve Problems For Pharmaceutical Industry
The pharmaceutical industry has experienced major growth recently - thanks to mobile technology As the world population continues to age, there is further demand for drugs and treatments that provide a healthier future for Baby Boomers and seniors

FDA Wants Drug Industry to Fit the Bill
On Thursday, the United States Food and Drug Administration asked for a large increase in the annual fees paid by the pharmaceutical industry. The money will go towards costs associated with testing new drugs prior to their approval.

Dosage Form Development And Closely Related Accessories
With the "return to nature" of the wind sweeping across the world, Natural medicine Much attention is paid to development of new drugs for the medicine opportunities. Chinese R & D of new drugs through a variety of ways, which will still using the traditional form of decoction or other applications classics party, Cuba, experience, etc. dosage side improved to better meet the modern needs as an important way. In a sense, able to produce high-quality preparations, whether the successful development of new dosage forms, sometimes depending on Pharmaceutical Excipients Matching supply.

Arrowhead Announces the Agenda for its 2nd Annual Drug Delivery Summit in San Francisco, California on May 1st and 2nd, 2008
Arrowhead Conferences has announced the agenda for its 2nd Annual Drug Delivery Summit: New Technologies and Commercialization Trends in San Francisco, California on May 1st and 2nd, 2008.

FDA Compliance And Medication Manufacturing
Very few people would say that pharmaceuticals affect our life in a major way. However, from birth to death we rely on medicines in one way or another. There is no age limit to who will use pharmaceuticals be it babies, teenagers or the elderly. Also, people who have long-term and chronic illnesses will also rely on medicines. FDA Compliance ensures that the drugs we take are as safe as possible. It does this by regulating manufacturers, facilities and the ingredients which go into pharmaceuticals.




Privacy Policy | Copyright/Trademark Notification